Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Severe joint pain was reported as worsened; This non-serious case was reported by a nurse via sales rep and described the occurrence of joint pain in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 week after receiving Shingrix, the patient experienced joint pain (Verbatim: Severe joint pain was reported as worsened). The outcome of the joint pain was not resolved. The reporter considered the joint pain to be related to Shingrix. The company considered the joint pain to be related to Shingrix. Additional Information: GSK Receipt Date: 23-JAN-2025 Severe joint pain was reported as worsened. Patient was otherwise healthy before first dose was administered. A week later, the patient complained of severe joint pain. They were referred to rheumatologist, and the labs were all normal according to the provider.